TrkA is a binding partner of NPM‐ALK that promotes the survival of ALK + T‐cell lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Molecular Oncology"
DOI: 10.1002/1878-0261.12088
Abstract: Nucleophosmin‐anaplastic lymphoma kinase‐expressing (NPM‐ALK+) T‐cell lymphoma is an aggressive neoplasm that is more commonly seen in children and young adults. The pathogenesis of NPM‐ALK+ T‐cell lymphoma is not completely understood. Wild‐type ALK is a receptor… read more here.
Keywords: alk cell; alk; npm alk; cell ... See more keywords